References
- MazzolaniFPilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathyClin Ophthalmol2012680180622701080
- WangMMunchICHaslerPWPrunteCLarsenMCentral serous chorioretinopathyActa Ophthalmol20088612614517662099
- GraefeAVUber centrale recidivierende retinitis [On central recurrent retinitis]Graefes Arch Clin Exp Ophthalmol186612211215 German
- GassJDPathogenesis of disciform detachment of the neuroepitheliumAm J Ophthalmol196763Suppl11396019308
- ArndtCSariAFerreMElectrophysiological effects of corticosteroids on the retinal pigment epitheliumInvest Ophthalmol Vis Sci20014247247511157885
- PrunteCFlammerJChoroidal capillary and venous congestion in central serous chorioretinopathyAm J Ophthalmol199612126348554078
- OchiaiJKatoMTanikawaHKobayashiY[The changes over time in areas of abnormal choroidal staining in central serous chorioretinopathy.]Nippon Ganka Gakkai zasshi2002106583589 Japanese12385124
- ChongCFYangDPhamTQLiuHnovel treatment of central serous chorioretinopathy with topical anti-inflammatory therapyBMJ Case Rep20122012piibcr2012006970
- Malchiodi-AlbediFMatteucciABernardoAMinghettiLPPAR-gamma, microglial cells, and ocular inflammation: new venues for potential therapeutic approachesPPAR Res2008200829578418382616
- MurataTHeSHangaiMPeroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularizationInvest Ophthalmol Vis Sci2000412309231710892878
- IijimaHIidaTMurayamaKImaiMGohdoTPlasminogen activator inhibitor 1 in central serous chorioretinopathyAm J Ophthalmol199912747747810218712
- CaccavaleAImparatoMRomanazziFNegriAPortaAFerentiniFA new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathyMed Hypotheses20097343543719427737
- GuptaSCKismaliGAggarwalBBCurcumin, a component of turmeric: from farm to pharmacyBioFactors20133921323339055
- ShehzadARehmanGLeeYSCurcumin in inflammatory diseasesBio Factors2013396977
- EsatbeyogluTHuebbePErnstIMChinDWagnerAERimbachGCurcumin – from molecule to biological functionAngew Chem Int Ed Engl2012515308533222566109
- ZhouHBeeversCSHuangSThe targets of curcuminCurr Drug Targets20111233234720955148
- BonneC[PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization.]J Fr Ophtalmol200528326330 French15883500
- SiddiquiAMCuiXWuRThe anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome prolif erator-activated receptor-gammaCrit Care Med2006341874188216715036
- JiangCTingATSeedBPPAR-gamma agonists inhibit production of monocyte inflammatory cytokinesNature199839182869422509
- ManikandanRThiagarajanRBeulajaSSudhandiranGArumugamMEffect of curcumin on selenite-induced cataractogenesis in Wistar rat pupsCurr Eye Res20103512212920136422
- ManikandanRThiagarajanRBeulajaSSudhandiranGArumugamMCurcumin prevents free radical-mediated cataractogenesis through modulations in lens calciumFree Radic Biol Med20104848349219932168
- ManikandanRThiagarajanRBeulajaSAnti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lensChem Biol Interact200918120220919481068
- AllegriPMastromarinoANeriPManagement of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-upClin Ophthalmol201041201120621060672
- WangLLSunYHuangKZhengLCurcumin, a potential therapeutic candidate for retinal diseasesMol Nutr Food Res2182013 [Epub ahead of print.]
- CuomoJAppendinoGDernASComparative absorption of a standardized curcuminoid mixture and its lecithin formulationJ Nat Prod20117466466921413691
- LeddaABelcaroGDugallMMeriva(R), a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry studyPanminerva Med2012541 Suppl 4172223241931
- SteigerwaltRNebbiosoMAppendinoGMeriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathyPanminerva Med2012541 Suppl 4111623241930
- AppendinoGBelcaroGCornelliUPotential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot studyPanminerva Med2011533 Suppl 1434922108476
- BelcaroGCesaroneMRDugallMEfficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patientsAltern Med Rev20101533734421194249
- BelcaroGCesaroneMRDugallMProduct-evaluation registry of Meriva(R), a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritisPanminerva Med2010522 Suppl 1556220657536
- IbrahimAEl-MeligyAFetaihHDessoukiAStoicaGBarhoumiREffect of curcumin and Meriva on the lung metastasis of murine mammary gland adenocarcinomaIn Vivo20102440140820668306
- BouzasEAMoretPPournarasCJCentral serous chorioretinopathy complicating solar retinopathy treated with glucocorticoidsGraefes Arch Clin Exp Ophthalmol19992371661689987635
- ZhaoMCelerierIBousquetEMineralocorticoid receptor is involved in rat and human ocular chorioretinopathyJ Clin Invest20121222672267922684104
- CaccavaleARomanazziFImparatoMNegriAMoranoAFerentiniFCentral serous chorioretinopathy: a pathogenetic modelClin Ophthalmol2011523924321386917
- SchaalKBHoehAEScheuerleASchuettFDithmarSIntravitreal bevacizumab for treatment of chronic central serous chorioretinopathyEur J Ophthalmol20091961361719551677
- ChenLYangPKijlstraADistribution, markers, and functions of retinal microgliaOcul Immunol Inflamm200210273912461701
- JacobAWuRZhouMWangPMechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activationPPAR Res200720078936918274631
- MarczyloTHStewardWPGescherAJRapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) methodJ Agric Food Chem20095779780319152267
- MarczyloTHVerschoyleRDCookeDNMorazzoniPStewardWPGescherAJComparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholineCancer Chemother Pharmacol20076017117717051370
- WangYJPanMHChengALStability of curcumin in buffer solutions and characterization of its degradation productsJ Pharm Biomed Anal199715186718769278892
- AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm2007480781817999464
- LiLBraitehFSKurzrockRLiposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesisCancer20051041322133116092118
- JurenkaJSAnti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical researchAltern Med Rev20091414115319594223
- LalBKapoorAKAsthanaOPEfficacy of curcumin in the management of chronic anterior uveitisPhytother Res19991331832210404539
- LalBKapoorAKAgrawalPKAsthanaOPSrimalRCRole of curcumin in idiopathic inflammatory orbital pseudotumoursPhytother Res20001444344710960899
- SharmaRAStewardWPGescherAJPharmacokinetics and pharmacodynamics of curcuminAdv Exp Med Biol200759545347017569224
- LaoCDRuffinMTtNormolleDDose escalation of a curcuminoid formulationBMC Complement Altern Med200661016545122
- BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
- MaitiKMukherjeeKGantaitASahaBPMukherjeePKCurcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in ratsInt J Pharm200733015516317112692
- AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends Pharmacol Sci200930859419110321
- BarryJFritzMBrenderJRSmithPELeeDKRamamoorthyADetermining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcuminJ Am Chem Soc20091314490449819256547
- AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol200941405918662800
- JeongSJKohWLeeEOAntiangiogenic phytochemicals and medicinal herbsPhytother Res20112511020564543
- ArbiserJLKlauberNRohanRCurcumin is an in vivo inhibitor of angiogenesisMol Med1998437638310780880
- KowluruRAKanwarMEffects of curcumin on retinal oxidative stress and inflammation in diabetesNutr Metab (Lond)20074817437639